4.5 Article

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

Rohit Loomba et al.

ANNALS OF INTERNAL MEDICINE (2008)

Review Hematology

Management of viral hepatitis in hematologic malignancies

Roberto J. Firpi et al.

BLOOD REVIEWS (2008)

Review Pharmacology & Pharmacy

Therapy of chronic hepatitis B: trends and developments

William E. Delaney et al.

CURRENT OPINION IN PHARMACOLOGY (2008)

Article Infectious Diseases

Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients

Pin-Nan Cheng et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)